107
Views
2
CrossRef citations to date
0
Altmetric
Research Articles

Biophysical Investigation and Antitumor Potential of Heterocyclic Palladium-Based Agent: Cytotoxicity, Spectroscopic and Molecular Docking Approaches in Interaction with Human Serum Albumin

, & ORCID Icon
Pages 91-109 | Received 02 Jan 2019, Accepted 15 Jan 2020, Published online: 10 Feb 2020

References

  • K.S. Prasad, L.S. Kumar, S. Chandan, R.M. Naveen Kumar, and H.D. Revanasiddappa, “Palladium(II) Complexes as Biologically Potent Metallo-Drugs: Synthesis, Spectral Characterization, DNA Interaction Studies and Antibacterial Activity,” Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 107 (2013): 108–16.
  • T.V. Serebryanskaya, T. Yung, A.A. Bogdanov, A. Shchebet, S.A. Johnsen, A.S. Lyakhov, L.S. Ivashkevich, Z.A. Ibrahimava, T.S. Garbuzenco, T.S. Kolesnikova, et al., “Synthesis, Characterization, and Biological Evaluation of New Tetrazole-Based Platinum(II) and Palladium(II) Chlorido Complexes Potent Cisplatin Analogues and Their Trans Isomers,” Journal of Inorganic Biochemistry 120, (2013): 44–53.
  • H. Mansouri-Torshizi, M. Saeidifar, F. Khosravi, A. Divsalar, A.A. Saboury, and F. Hassani, “DNA Binding and Antitumor Activity of Alpha-Diimineplatinum(II) and Palladium(II) Dithiocarbamate Complexes,” Bioinorganic Chemistry and Applications 2011, (2011): 1–11.
  • A. Aliabadi, S. Andisheh, Z. Tayarani-Najaran, and M. Tayarani-Najaran, “2-(4-Fluorophenyl)-N-Phenylacetamide Derivatives as Anticancer Agents: Synthesis and In-Vitro Cytotoxicity Evaluation,” Iranian Journal of Pharmaceutical Research 12, (2013): 267–71. 12 PMC3813262.
  • J. Ruiz, C. Vicente, C. de Haro, and D. Bautista, “Novel bis-C,N-Cyclometalated Iridium(III) Thiosemicarbazide Antitumor Complexes: Interactions with Human Serum Albumin and DNA, and Inhibition of Cathepsin B,” Inorganic Chemistry 52 no. 2 (2013): 974–82.
  • Y.C. Duan, Y.C. Ma, E. Zhang, X.J. Shi, M.M. Wang, X.W. Ye, and H.M. Liu, “Design and Synthesis of Novel 1,2,3-Triazole-Dithiocarbamate Hybrids as Potential Anticancer Agents,” European Journal of Medicinal Chemistry 62, (2013): 11–19.
  • M. Saeidifar, H. Mansouri-Torshizi, A. Divsalar, and A.A. Saboury, “Novel 2,2′-Bipyridine Palladium(II) Complexes with Glycine Derivatives: Synthesis, Characterization, Cytotoxic Assays and DNA-Binding Studies,” Journal of the Iranian Chemical Society 10, no. 5 (2013): 1001–11.
  • I. Ali, W.A. Wani, K. Saleem, and M.-F. Hseih, “Design and Synthesis of Thalidomide Based Dithiocarbamate Cu(II), Ni(II) and Ru(III) Complexes as Anticancer Agents,” Polyhedron 56, (2013): 134–43.
  • F. Carta, M. Aggarwal, A. Maresca, A. Scozzafava, R. McKenna, E. Masini, and C.T. Supuran, “Dithiocarbamates Strongly Inhibit Carbonic Anhydrases and Show Antiglaucoma Action In Vivo,” Journal of Medicinal Chemistry 55 no. 4 (2012): 1721–30.
  • F.K. Keter, I.A. Guzei, and J. Darkwa, “N-Heterocyclic Dithiocarbamate Platinum(II) Complexes: Unexpected Transformation of Dithiocarbamate to Oxodithiocarbonate in Phosphinoplatinum Complexes in Solution,” Inorganic Chemistry Communications 27, (2013): 60–63.
  • M. Zhu, L. Wang, H. Zhang, S. Fan, Z. Wang, Q.X. Li, Y. Wang, and S. Liu, “Interactions Between Tetrahydroisoindoline-1,3-Dione Derivatives and Human Serum Albumin via Multiple Spectroscopy Techniques,” Environmental Science and Pollution Research 25 (2018): 17735–48.
  • Y. Wang, G. Zhang, and L. Wang, “Interaction of Prometryn to Human Serum Albumin: Insights from Spectroscopic and Molecular Docking Studies, Pestic,” Pesticide Biochemistry and Physiology 108, (2014): 66–73.
  • Q. Wang, S.R. Zhang, and X. Ji, “Investigation of Interaction of Antibacterial Drug Sulfamethoxazole with Human Serum Albumin by Molecular Modeling and Multi-Spectroscopic Method,” Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 124, (2014): 84–90.
  • X. Zhang, H. Zhai, R. Gao, J. Zhang, Y. Zhang, and X. Zheng, “Study on the Interaction Between 4-Thio-5-Methyluridine and Human Serum Albumin by Spectroscopy and Molecular Modeling,” Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 121, (2014): 724–31.
  • L. Wang, X. Wu, Y. Yang, X. Liu, M. Zhu, S. Fan, Z. Wang, J. Xue, R. Hua, Y. Wang, et al., “Multi-Spectroscopic Measurements, Molecular Modeling and Density Functional Theory Calculations for Interactions of 2,7-Dibromocarbazole and 3,6-Dibromocarbazole with Serum Albumin,” Science of the Total Environment 686, (2019): 1039–1048.
  • Y. Wang, Z. Wang, M. Zhu, J. Liu, R. Na, F. Liu, X. Wu, S. Fan, D. Pan, J. Tang, et al., “Comparative Interactions of Dihydroquinazolin Derivatives with Human Serum Albumin Observed via Multiple Spectroscopy,” Applied Sciences 7 no. 2 (2017): 200–216.
  • Y. Wang, J. Liu, M. Zhu, L. Wang, X. Zen, S. Fan, Z. Wang, H. Li, R. Na, X. Zhao, et al., “Biophysical Characterization of Interactions between Falcarinol-Type Polyacetylenes and Human Serum Albumin via Multispectroscopy and Molecular Docking Techniques,” Journal of Luminescense 200, (2018): 111–19.
  • Y. Wang, L. Wang, M. Zhu, J. Xue, R. Hua, and Q.X. Li, “Comparative Studies on Biophysical Interactions between Gambogic Acid and Serum Albumin via Multispectroscopic Approaches and Molecular Docking,” Journal of Luminescense 205, (2019): 210–18.
  • H. Mansouri-Torshizi, M. Saeidifar, A. Divsalar, and A.A. Saboury, “Study on Interaction of DNA from Calf Thymus with 1,10-Phenanthrolinehexyldithiocarbamatopalladium(ii) Nitrate as Potential Antitumor Agent,” Journal of Biomolecular Structure and Dynamics 28, (2011): 805–14.
  • G. Rabbani, M.H. Baig, A.T. Jan, E.J. Lee, M.V. Khan, M. Zaman, A.A. Farouk, R.H. Khan, and I. Choi, “Binding of Erucic Acid with Human Serum Albumin Using a Spectroscopic and Molecular Docking Study,” International Journal of Biological Macromolecules 105, (2017): 1572–80.
  • Y. Shu, W. Xue, X. Xu, Z. Jia, X. Yao, S. Liu, and L. Liu, “Interaction of Erucic Acid with Bovine Serum Albumin Using a Multi-Spectroscopic Method and Molecular Docking Technique,” Food Chemistry 173, (2015): 31–37.
  • C. Dong, S. Ma, and Y. Liu, “Studies of the Interaction between Demeclocycline and Human Serum Albumin by Multi-Spectroscopic and Molecular Docking Methods,” Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 103, (2013): 179–86.
  • M. Saeidifar, H. Mirzaei, N. Ahmadi Nasab, and H. Mansouri-Torshizi, “Mononuclear Pd(II) Complex as a New Therapeutic Agent: Synthesis, Characterization, Biological Activity, Spectral and DNA Binding Approaches,” Journal of Molecular Structure 1148, (2017): 339–46.
  • M. Hosseini-Kharat, K. Karami, M. Saeidifar, C. Rizzoli, R. Zahedi-Nasab, Z. Sohrabijam, and T. Sharifi, “A Novel Pd(II) CNO Pincer Complex of MR (Methyl Red): Synthesis, Crystal Structure, Interaction with Human Serum Albumin (HSA) in Vitro and Molecular Docking,” New Journal of Chemistry 41 no. 18 (2017): 9897–907.
  • I.P. Caruso, W. Vilegas, M.A. Fossey, and M.L. Cornelio, “Exploring the Binding Mechanism of Guaijaverin to Human Serum Albumin: Fluorescence Spectroscopy and Computational Approach,” Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 97, (2012): 449–55.
  • N. Shahabadi and S. Hadidi, “Mechanistic and Conformational Studies on the Interaction of a Platinum(II) Complex Containing an Antiepileptic Drug, Levetiracetam, with Bovine Serum Albumin by Optical Spectroscopic Techniques in Aqueous Solution,” Applied Biochemistry and Biotechnology 175 no. 4 (2015): 1843–57.
  • P.B. Kandagal, S. Ashoka, J. Seetharamappa, S.M.T. Shaikh, Y. Jadegoud, and O.B. Ijare, “Study of the Interaction of an Anticancer Drug with Human and Bovine Serum Albumin: Spectroscopic Approach,” Journal of Pharmaceutical and Biomedical Analysis 41 no. 2 (2006): 393–9.
  • R. Mi, Y.J. Hu, X.Y. Fan, Y. Ouyang, and A.M. Bai, “Exploring the Site-Selective Binding of Jatrorrhizine to Human Serum Albumin: spectroscopic and Molecular Modeling Approaches,” Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 117, (2014): 163–9.
  • A. Divsalar, A.A. Saboury, A.A. Moosavi-Movahedi, and H. Mansoori-Torshizi, “Comparative Analysis of Refolding of Chemically Denatured Beta-Lactoglobulin Types A and B Using the Dilution Additive Mode,” International Journal of Biological Macromolecules 38 no. 1 (2006): 9–17.
  • A. Divsalar, A.A. Saboury, M. Nabiuni, Z. Zare, M.E. Kefayati, and A. Seyedarabi, “Characterization and Side Effect Analysis of a Newly Designed Nanoemulsion Targeting Human Serum Albumin for Drug Delivery,” Colloids and Surfaces B: Biointerfaces 98, (2012): 80–84.
  • Y. Wang, Z. Wang, M. Zhu, F. Liu, X. Wu, D. Pan, J. Liu, S. Fan, J. Tang, R. Na, et al., “Comparative Studies of Interactions between Fluorodihydroquinazolin Derivatives and Human Serum Albumin with Fluorescence Spectroscopy,” Molecules 21 no. 10 (2016): 1373–1386.
  • R.J. Lakowicz, Principles of Fluorescence Spectroscopy, 3rd ed. (New York: Springer, 2006).
  • R. Punith and J. Seetharamappa, “Spectral Characterization of the Binding and Conformational Changes of Serum Albumins upon Interaction with an Anticancer Drug, Anastrozole,” Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 92, (2012): 37–41.
  • S. Tabassum, W.M. Al-Asbahy, M. Afzal, and F. Arjmand, “Synthesis, Characterization and Interaction Studies of Copper Based Drug with Human Serum Albumin (HSA): Spectroscopic and Molecular Docking Investigations,” Journal of Photochemistry and Photobiology B: Biology 114, (2012): 132–139.
  • Y. Shi, H. Liu, M. Xu, Z. Li, G. Xie, L. Huang, and Z. Zeng, “Spectroscopic Studies on the Interaction between an Anticancer Drug Ampelopsin and Bovine Serum Albumin,” Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 87, (2012): 251–7.
  • J. Zhu, L. Chen, Y. Dong, J. Li, and X. Liu, “Spectroscopic and Molecular Modeling Methods to Investigate the Interaction between 5-Hydroxymethyl-2-Furfural and Calf Thymus DNA Using Ethidium Bromide as a Probe,” Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 124, (2014): 78–83.
  • Z. Cheng, “Interaction of Tetramethylpyrazine with Two Serum Albumins by a Hybrid Spectroscopic Method,” Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 93, (2012): 321–30.
  • G. Tsuji, K. Kawakami, and S. Sasaki, “Enantioselective Binding of Chiral 1,14-Dimethyl[5]Helicene-Spermine Ligands with B- and Z-DNA,” Bioorganic & Medicinal Chemistry 21 no. 19 (2013): 6063–68.
  • F. Janati Fard, Z. Mashhadi Khoshkhoo, H. Mirtabatabaei, M.R. Housaindokht, R. Jalal, H.E. Hosseini, M.R. Bozorgmehr, A.A. Esmaeili, and M.J. Khoshkholgh, “Synthesis, Characterization and Interaction of N,N’-Dipyridoxyl (1,4-Butanediamine) Co(III) Salen Complex with DNA and HSA,” Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 97, (2012): 74–82.
  • A.Y. Khan, M. Hossain, and G.S. Kumar, “Investigations on the Interaction of the Phototoxic Alkaloid Coralyne with Serum Albumins,” Chemosphere 87 no. 7 (2012): 775–81.
  • A. Ray, B.K. Seth, U. Pal, and S. Basu, “Nickel(II)-Schiff Base Complex Recognizing Domain II of Bovine and Human Serum Albumin: Spectroscopic and Docking Studies,” Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 92, (2012): 164–74.
  • M. Xu, Z.R. Ma, L. Huang, F.J. Chen, and Z.Z. Zeng, “Spectroscopic Studies on the Interaction between Pr(III) Complex of an Ofloxacin Derivative and Bovine Serum Albumin or DNA,” Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 78 no. 1 (2011): 503–11.
  • J. Li, J. Li, Y. Jiao, and C. Dong, “Spectroscopic Analysis and Molecular Modeling on the Interaction of Jatrorrhizine with Human Serum Albumin (HSA),” Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 118, (2014): 48–54.
  • F. Dangkoob, M.R. Housaindokht, A. Asoodeh, O. Rajabi, Z. Rouhbakhsh Zaeri, and A. Verdian Doghaei, “Spectroscopic and Molecular Modeling Study on the Separate and Simultaneous Bindings of Alprazolam and Fluoxetine Hydrochloride to Human Serum Albumin (HSA): With the Aim of the Drug Interactions Probing,” Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 137, (2015): 1106–19.
  • X. Wang, Y. Liu, L.L. He, B. Liu, S.Y. Zhang, X. Ye, J.J. Jing, J.F. Zhang, M. Gao, and X. Wang, “Spectroscopic Investigation on the Food Components-Drug Interaction: The Influence of Flavonoids on the Affinity of Nifedipine to Human Serum Albumin,” Food and Chemical Toxicology 78, (2015): 42–51.
  • L. Lai, C. Lin, Z.Q. Xu, X.L. Han, F.F. Tian, P. Mei, D.W. Li, Y.S. Ge, F.L. Jiang, Y.Z. Zhang, et al., “Spectroscopic Studies on the Interactions Between CdTe Quantum Dots Coated with Different Ligands and Human Serum Albumin,” Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 97, (2012): 366–76.
  • X. Li and S. Wang, “Study on the Interaction of (+)-Catechin with Human Serum Albumin Using Isothermal Titration Calorimetry and Spectroscopic Techniques,” New Journal of Chemistry 39 no. 1 (2015): 386–95.
  • A. Hasanzadeh, G. Dehghan, M. Shaghaghi, Y. Panahi, A. Jouyban, and R. Yekta, “Multispectral and Molecular Docking Studies on the Interaction of Human Serum Albumin with Iohexol,” Journal of Molecular Liquids 248, (2017): 459–67.
  • O.A. Chaves, B. Mathew, D. Cesarin-Sobrinho, B. Lakshminarayanan, M. Joy, G.E. Mathew, J. Suresh, and J.C. Netto-Ferreira, “Spectroscopic, Zeta Potential and Molecular Docking Analysis on the Interaction between Human Serum Albumin and Halogenated Thienyl Chalcones,” Journal of Molecular Liquids 242, (2017): 1018–26.
  • W. Song, M.Z. Ao, Y. Shi, L.F. Yuan, X.X. Yuan, and L.J. Yu, “Interaction Between Phillygenin and Human Serum Albumin Based on Spectroscopic and Molecular Docking,” Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 85 no. 1 (2012): 120–6.
  • M. Saeidifar, H. Mansouri-Torshizi, Y. Palizdar, A. Divsalar, and A.A. Saboury, “Synthesis, Characterization, and Cytotoxicity Studies of a Novel Palladium(II) Complex and Evaluation of DNA-Binding Aspects,” Nucleosides Nucleotides Nucleic Acids 32 no. 7 (2013): 366–88.
  • M. Saeidifar, H. Mansouri-Torshizi, A. Divsalar, and A.A. Saboury, “Spectroscopic Investigation on the Binding of the Antitumoral Pd(II) Complex to Human Serum Albumin,” Journal of the Chinese Chemical Society 60 no. 2 (2013): 133–9.
  • M. Saeidifar, A. Khanlarkhani, M. Eslami-Moghaddam, H. Mansouri-Torshizi, and A. Saboury, “Investigation of the Binding Behavior between the S-heterocyclic Aromatic Palladium(II) Complex and Human Serum Albumin: Spectroscopic Approach,” Polycyclic Aromatic Compounds 36 no. 1 (2015):1–18.
  • M. Saeidifar and H. Mansouri-Torshizi, “Investigation of the Interaction between Human Serum Albumin and Antitumor Palladium(II) Complex Containing 1,10-Phenanthroline and Dithiocarbamate Ligands,” Nucleosides Nucleotides Nucleic Acids 34 no. 1 (2015): 16–32.
  • S. Paul, N. Sepay, S. Sarkar, P. Roy, S. Dasgupta, P.S. Sardar, and A. Majhi, “Interaction of Serum Albumins with Fluorescent Ligand 4-Azido Coumarin: Spectroscopic Analysis and Molecular Docking Studies,” New Journal of Chemistry 41 no. 24 (2017): 15392–404.
  • M. Zhu, L. Wang, Y. Wang, J. Zhou, J. Ding, W. Li, Y. Xin, S. Fan, Z. Wang, and Y. Wang, “Biointeractions of Herbicide Atrazine with Human Serum Albumin: UV-Vis, Fluorescence and Circular Dichroism Approaches,” International Journal of Environmental Research and Public Health 15, (2018): 116–32.
  • Y. Yue, J. Liu, R. Liu, Q. Dong, and J. Fan, “Binding of Helicid to Human Serum Albumin: A Hybrid Spectroscopic Approach and Conformational Study,” Spectrochimica Acta Part A 124, (2014): 46–51.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.